QA: Globestar Therapeutics Corp in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001502152_2015_Globestar_Therapeutics_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001502152, Globestar Therapeutics Corp

  xvar xval
0 AssetsCurrent 29,262
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 448,341
4 LiabilitiesCurrent 560,760
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 21,278
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 502,772
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 52,047
11 remainder_Revenues 97,252
12 remainder_NetIncome -787,603
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 477,603
1 Liabilities 582,038
2 Expenses 554,819
3 Revenues 97,252
4 StockholdersEquity -104,435
5 NetIncome -1,245,170
6 ComprehensiveNetIncome -1,245,170
7 BaseVar 1,249,658
8 EconomicCapitalRatiobeforeLimitedLiability -2.78
9 EconomicCapitalRatio 0.760

Edgar->Model Mapping

Feature Distribution

Change over Time